vs

Side-by-side financial comparison of OOMA INC (OOMA) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $67.6M, roughly 1.1× OOMA INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 3.8%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $5.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 4.7%).

Ooma, Inc. is an American publicly traded telecommunications company based in the Silicon Valley, California area. Ooma offers communications services including Voice over IP (VoIP) calling for business, home and mobile users.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

OOMA vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.1× larger
PBYI
$75.5M
$67.6M
OOMA
Growing faster (revenue YoY)
PBYI
PBYI
+23.9% gap
PBYI
27.7%
3.8%
OOMA
More free cash flow
PBYI
PBYI
$8.9M more FCF
PBYI
$14.4M
$5.4M
OOMA
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
4.7%
OOMA

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
OOMA
OOMA
PBYI
PBYI
Revenue
$67.6M
$75.5M
Net Profit
$1.4M
Gross Margin
60.2%
69.3%
Operating Margin
1.9%
22.7%
Net Margin
2.1%
Revenue YoY
3.8%
27.7%
Net Profit YoY
158.9%
EPS (diluted)
$0.05
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OOMA
OOMA
PBYI
PBYI
Q4 25
$67.6M
$75.5M
Q3 25
$66.4M
$54.5M
Q2 25
$65.0M
$52.4M
Q1 25
$65.1M
$46.0M
Q4 24
$65.1M
$59.1M
Q3 24
$64.1M
$80.5M
Q2 24
$62.5M
$47.1M
Q1 24
$61.7M
$43.8M
Net Profit
OOMA
OOMA
PBYI
PBYI
Q4 25
$1.4M
Q3 25
$1.3M
$8.8M
Q2 25
$-141.0K
$5.9M
Q1 25
$3.0M
Q4 24
$-2.4M
Q3 24
$-2.1M
$20.3M
Q2 24
$-2.1M
$-4.5M
Q1 24
$-4.8M
Gross Margin
OOMA
OOMA
PBYI
PBYI
Q4 25
60.2%
69.3%
Q3 25
60.6%
77.7%
Q2 25
61.8%
76.5%
Q1 25
61.3%
77.1%
Q4 24
60.3%
76.4%
Q3 24
60.3%
63.9%
Q2 24
61.0%
77.4%
Q1 24
61.2%
75.5%
Operating Margin
OOMA
OOMA
PBYI
PBYI
Q4 25
1.9%
22.7%
Q3 25
1.4%
17.6%
Q2 25
-0.1%
12.7%
Q1 25
-0.5%
8.7%
Q4 24
-3.5%
22.6%
Q3 24
-2.5%
27.4%
Q2 24
-4.4%
-4.6%
Q1 24
-3.9%
-5.3%
Net Margin
OOMA
OOMA
PBYI
PBYI
Q4 25
2.1%
Q3 25
1.9%
16.2%
Q2 25
-0.2%
11.2%
Q1 25
6.5%
Q4 24
-3.6%
Q3 24
-3.3%
25.2%
Q2 24
-3.4%
-9.6%
Q1 24
-11.0%
EPS (diluted)
OOMA
OOMA
PBYI
PBYI
Q4 25
$0.05
$0.26
Q3 25
$0.04
$0.17
Q2 25
$-0.01
$0.12
Q1 25
$-0.01
$0.06
Q4 24
$-0.09
$0.40
Q3 24
$-0.08
$0.41
Q2 24
$-0.08
$-0.09
Q1 24
$-0.12
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OOMA
OOMA
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$21.7M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$90.0M
$130.3M
Total Assets
$152.7M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OOMA
OOMA
PBYI
PBYI
Q4 25
$21.7M
$97.5M
Q3 25
$19.6M
$94.4M
Q2 25
$19.0M
$96.0M
Q1 25
$17.9M
$93.2M
Q4 24
$17.1M
$101.0M
Q3 24
$16.6M
$96.7M
Q2 24
$15.6M
$96.8M
Q1 24
$17.5M
$107.2M
Total Debt
OOMA
OOMA
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$0
$56.7M
Q4 24
$3.0M
$68.0M
Q3 24
$8.5M
$79.3M
Q2 24
$11.5M
$90.7M
Q1 24
$16.0M
$102.0M
Stockholders' Equity
OOMA
OOMA
PBYI
PBYI
Q4 25
$90.0M
$130.3M
Q3 25
$88.1M
$115.3M
Q2 25
$87.7M
$104.7M
Q1 25
$85.3M
$97.1M
Q4 24
$83.5M
$92.1M
Q3 24
$81.8M
$71.1M
Q2 24
$81.0M
$48.5M
Q1 24
$78.1M
$51.0M
Total Assets
OOMA
OOMA
PBYI
PBYI
Q4 25
$152.7M
$216.3M
Q3 25
$150.1M
$202.9M
Q2 25
$148.8M
$194.9M
Q1 25
$149.2M
$196.2M
Q4 24
$149.6M
$213.3M
Q3 24
$151.5M
$220.7M
Q2 24
$155.2M
$205.0M
Q1 24
$159.3M
$214.1M
Debt / Equity
OOMA
OOMA
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.00×
0.58×
Q4 24
0.04×
0.74×
Q3 24
0.10×
1.12×
Q2 24
0.14×
1.87×
Q1 24
0.20×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OOMA
OOMA
PBYI
PBYI
Operating Cash FlowLast quarter
$6.9M
$14.4M
Free Cash FlowOCF − Capex
$5.4M
$14.4M
FCF MarginFCF / Revenue
8.1%
19.1%
Capex IntensityCapex / Revenue
2.2%
0.0%
Cash ConversionOCF / Net Profit
4.97×
TTM Free Cash FlowTrailing 4 quarters
$19.1M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OOMA
OOMA
PBYI
PBYI
Q4 25
$6.9M
$14.4M
Q3 25
$6.4M
$9.7M
Q2 25
$3.7M
$14.1M
Q1 25
$7.8M
$3.6M
Q4 24
$8.1M
$15.6M
Q3 24
$7.1M
$11.0M
Q2 24
$3.6M
$1.0M
Q1 24
$5.5M
$11.2M
Free Cash Flow
OOMA
OOMA
PBYI
PBYI
Q4 25
$5.4M
$14.4M
Q3 25
$5.0M
$9.7M
Q2 25
$2.5M
$14.1M
Q1 25
$6.1M
$3.6M
Q4 24
$6.5M
$15.6M
Q3 24
$5.3M
$11.0M
Q2 24
$2.1M
$1.0M
Q1 24
$4.2M
FCF Margin
OOMA
OOMA
PBYI
PBYI
Q4 25
8.1%
19.1%
Q3 25
7.6%
17.7%
Q2 25
3.8%
26.8%
Q1 25
9.4%
7.7%
Q4 24
10.0%
26.4%
Q3 24
8.3%
13.7%
Q2 24
3.4%
2.1%
Q1 24
6.9%
Capex Intensity
OOMA
OOMA
PBYI
PBYI
Q4 25
2.2%
0.0%
Q3 25
2.0%
0.0%
Q2 25
1.9%
0.0%
Q1 25
2.6%
0.1%
Q4 24
2.4%
0.0%
Q3 24
2.7%
0.0%
Q2 24
2.3%
0.0%
Q1 24
2.1%
0.0%
Cash Conversion
OOMA
OOMA
PBYI
PBYI
Q4 25
4.97×
Q3 25
5.07×
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OOMA
OOMA

Subscription And Services Revenue$62.0M92%
Product And Other Revenue$5.7M8%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons